BUY Privi Speciality Chemicals Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)1 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
4 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·8 Oct · 1mo ago
Outcome of Board Meeting - Financial Results for quarter and half year ended September 30, 2026
BSE · Result·29 Oct · 1w ago
Outcome of the Board Meeting held on October 29, 2026 inter alia to consider & approve Financial Results for quarter and half year ended September 30, 2026 & declaration of first Interim ....
BSE · Board Meeting·29 Oct · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Privi Speciality Chemicals
- BUY — Siddharth Sedani, Anand Rathi8 Oct 2026 · ~1 year · target ₹4,600 · Active
- BUY — Sudeep Shah, SBICAP Securities29 Sept 2026 · ~3 months · target ₹3,850 · SL hit
- BUY — Sudeep Shah, SBICAP Securities28 Sept 2026 · ~2 weeks · target ₹3,720 · SL hit
- BUY — Kush Bohra25 Sept 2026 · ~2 weeks · target ₹3,700 · Target hit
- BUY — Sandeep Jain, Tradeswift23 Sept 2026 · ~1 year · target ₹3,950 · Active
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

